NeuroTrax Corporation is a growth stage company focused on novel and technologically advanced methods for assessment of neurocognitive disorders. Experts agree that precise and early detection of neurocognitive disorders like dementia is critical for effective treatment pathways, and NeuroTrax® is working to bring advanced methods for valid and reliable early detection empowering improved patient care for patients of physicians and hospitals around the world.